Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Delgocitinib synthesis patent large scale process?Ulipristal acetate price philippines?Orforglipron fda status 2026?Amphotericin b tablet price?Delgocitinib manufacturing process patent?
See the DrugPatentWatch profile for phexxi
Phexxi does not have a patent that has expired, as it is a relatively new product. Phexxi is a vaginal gel contraceptive [1]. Its active ingredients are lactic acid, ascorbic acid, and potassium bitartrate [1].
Phexxi was approved by the U.S. Food and Drug Administration (FDA) in December 2019 and became commercially available in early 2020 [1][2].
Phexxi is used to prevent pregnancy. It works by maintaining a vaginal pH between 3.5 and 4.5, which is not conducive to sperm survival [1].
Unlike hormonal contraceptives, Phexxi does not contain hormones [1]. It is a non-hormonal option that is used by women on demand, at the time of intercourse [1].
Phexxi is manufactured by Evofem Biosciences [1].
Information about drug patents and their expiration dates can be found on DrugPatentWatch.com [3]. Sources: [1] https://www.phexxi.com/ [2] https://www.accessdata.fda.gov/scripts/drugObManual/ [3] https://drugpatentwatch.com/
Other Questions About Phexxi :